Glucagon regulates blood glucose via control of hepatic glycogenolysis and gluconeogenesis and via regulation of insulin release from the β cell. Pharmacological administration of glucagon increases blood glucose in normal and diabetic subjects, and produces positive inotropic and chronotropic cardiovascular effects, relaxation of smooth muscle in the gastrointestinal tract and stimulation of growth hormone secretion. The actions of glucagon are mediated via a single adenylate cyclase-coupled glucagon receptor that also couples to the phospholipase Cinositol phosphate (PLC-IP) pathway leading to Ca2+ release from intracellular stores.
|Stability:||20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)|
|Freeze Medium:||90% FBS+10% DMSO|
|Culture Medium:||DMEM +10%FBS+2ug/ml puromycin+200ug/ml hygromycin|
|Storage:||Liquid nitrogen immediately upon delivery|
Functional assay for GCGR receptor
|Ⅲ. Description of Host Cell Line|
|Ⅳ. Representative Data|
Figure 1. GCGR/CRE Luc Reporter -HEK293 Recombinant Cell Line(C21).